Strain Catalog

Showing results 6901 to 7000 of 7208

< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 Next >
Strain Descriptor Strain Summary Genotype Phenotype
[dscB]:GFP:rab8Aoverexpressor of rab8A tagged with GFP at the amino terminusaxeA2, axeB2, axeC2, [dscB]:GFP:ras8A, neoR
[dscB]:GFP:rab8A(N128I)overexpressor of rab8A(N128I)tagged with GFP at the amino terminusaxeA2, axeB2, axeC2, [dscB]:GFP:ras8A(N128I), neoR
[dscB]:GFP:rab8A(Q74L)overexpressor of rab8A(Q74L) tagged with GFP at the amino terminusaxeA2, axeB2, axeC2, [dscB]:GFP:ras8A(Q74L), neoR
[dscB]:GFP:rab8Boverexpressor of rab8BaxeA2, axeB2, axeC2, [dscB]:GFP:ras8B, neoR
[dscB]:GFP:rab8B(Q74L)overexpressor of rab8B(Q74L) tagged with GFP at the amino terminusaxeA2, axeB2, axeC2, [dscB]:GFP:ras8B(Q74L), neoR
[dscB]:GFP:vamp7AGFP-VAMP7 expressed in DH1-10 cellsaxeA1, axeB1, axeC1, pyr5-6- [pRG24], ura-, GFP:VAMP7, neoR
[dscB]:GFP:vamp7A(L35A)GFP-VAMP7[L35A] mutant (dileucine signal ablated) expressed in DH-10 cellsaxeA1, axeB1, axeC1, pyr5-6- [pRG24], ura-, GFP:VAMP7(L35A), neoR
[dscB]:HA:racCfolate-inducible, racC under the control of the dscB promoter in AX2axeA2, axeB2, axeC2, racC, [pVEII], neoR
[dscB]:HA:rapB(G12V)folate-inducible, N-terminal HA-tagged, constitutively active RapB with G12V substitution under the control of the dscB promoter in AX4 cellsaxeA1, axeB1, axeC1, HA:rapA(G12V), [pVEII], neoR
[dscB]:myc:rac1Boverexpressor of myc-tagged rac1BaxeA1, axeB1, axeC1, [dscB]:myc:rac1B, neoR
[dscB]:myc:rac1B(G12V)overexpressor of myc-tagged rac1B(G12V) (constitutively active)axeA1, axeB1, axeC1, [dscB]:myc:rac1B(G12V), neoR
[dscB]:myc:rac1B(Q61L)overexpressor of myc-tagged rac1B(Q61L) (constitutively active)axeA1, axeB1, axeC1, [dscB]:myc:rac1B(Q61L) neoR
[dscB]:myc:rac1B(T17N)overexpressor of myc-tagged rac1B(T17N) (constitutively inctive)axeA1, axeB1, axeC1, [dscB]:myc:rac1B(T17N) neoR
[dscB]:rac1B(G12V):mycfolate-inducible, constitutively active Rac1B with G12V substitution under the control of the dscB promoter in AX3-ORF+axeA1, axeB1, axeC1, pyr5-6-[pRG24], [Ddp2-ORF-pyr5-6], ura+, rac1B(G12V), [pDXD-3C], neoR
[dscB]:rac1B(Q61L):mycfolate-inducible, constitutively active Rac1B with Q61L substitution under the control of the dscB promoter in AX3-ORF+axeA1, axeB1, axeC1, pyr5-6-[pRG24], [Ddp2-ORF-pyr5-6], ura+, rac1B(Q61L), [pDXD-3C], neoR
[dscB]:rac1B(T17N):mycfolate-inducible, dominant negative Rac1B with T17N substitution under the control of the dscB promoter in AX3-ORF+axeA1, axeB1, axeC1, pyr5-6-[pRG24], [Ddp2-ORF-pyr5-6], ura+, rac1B(T17N), [pDXD-3C], neoR
[dscB]:rapAfolate-inducible, RapA under the control of the dscB promoter in AX2 cellsaxeA2, axeB2, axeC2, rapA, [pVEII], neoR
[dscB]:rapA(D40E)folate-inducible, RapA with D40E substitution under the control of the dscB promoter in AX2 cellsaxeA2, axeB2, axeC2, rapA(D40E), [pVEII], neoR
[dscB]:rapA(F160L)folate-inducible, RapA with F160L substitution under the control of the dscB promoter in AX2 cellsaxeA2, axeB2, axeC2, rapA(F160L), [pVEII], neoR
[dscB]:rapA(G12T)folate-inducible, constitutively active RapA with G12T substitution under the control of the dscB promoter in AX2 cellaxeA2, axeB2, axeC2, rapA(G12T), [pVEII], neoR
[dscB]:rapA(G12V)rapA(G12V) under the control of the discoidin promoteraxeA2, axeB2, axeC2, [dscB]:rapA(G12V), neoR
[dscB]:rapA(S19N)folate-inducible, RapA with S19N substitution under the control of the dscB promoter in AX2 cellsaxeA2, axeB2, axeC2, rapA(S19N), [pVEII], neoR
[dscB]:rapA(T63Q)folate-inducible, RapA with T63Q substitution under the control of the dscB promoter in AX2 cellsaxeA2, axeB2, axeC2, rapA(T63Q), [pVEII], neoR
[dscB]:rasG(G12T)rasG(G12T) under the control of the discoidin promoter (constitutively active)axeA2, axeB2, axeC2, [dscB]:rasG(G12T), neoR
[dscB]:rasG(G12T/T45Q)constitutively active rasG(G12T/T45Q under the control of the discoidin promoteraxeA2, axeB2, axeC2, [dscB]:rasG(G12T/T45Q), neoR
[dscB]:rasG(S17N)rasG(S17N) under the control of the discoidin promoter (dominant negative)axeA2, axeB2, axeC2, [dscB]:rasG(S17N), neoR
[dscB]:RFP:syn7ARFP-SYN7A under the control of the discoidin promoter, expressed in DH1-10 cellsaxeA1, axeB1, axeC1, pyr5-6- [pRG24], ura-, GFP:syn7A, bsR
[dscC]:kif2kif2 under control of dscC promotor overexpressed in AX2axeA2, axeB2, axeC2, kif2, [pBIG], neoR
[ecmAO]:ile-GFPunstable GFP which does not accumulate with time and thus gives generally weak fluorescenceaxeA2, axeB2, axeC2, [ecmAO/ile-wt-GFP]. neoRneoR
[ecmAO]:rasG(G12T)constitutively active rasG with G12T substitution under control of prestalk ecmAO promotor in AX2axeA2, axeB2, axeC2, rasG(G12T), [pTZ19R], neoR
[ecmA]:GFPAX4 cells expressing GFP under the control of the prestalk ecmA promoter axeA1, axeB1, axeC1, [ecmA::GFP], neoRaxe,neoR,wt
[ecmA]:lacZHL328 (uracil auxotroph) cells expressing lacZ under the control of the prestalk ecmA promoteraxeA1, axeB1, axeC1, pyr5-6-[pdeltaPYR-BglII], ura-, [ecmA::lacZ], neoRaxe, ura-, neoR
[ecmA]:lacZAX4 expressing lacZ from the prestalk promoter ecmAaxeA1, axeB1, axeC1, [ecmA::lacZ], neoRaxe,neoR
[ecmA]:pkaCpkaC overexpressed under control of the prestalk emcA promotor in AX3 cellsaxeA1, axeB1, axeC1, pkaC, neoR
[ecmA]:pkaC(9-648)PkaC over expressed in AX2 under control of pre-stalk ecmA promotoraxeA2, axeB2, axeC2, pkaC(9-648), [ecmA-pkaC], neoR
[ecmA]:pkaR(G135E/G261A)constitutively active pkaR (PKA regulatory subunit; point mutant (G135E/G261A) that is unable to bind cAMP under control of ecmA promotoraxeA2, axeB2, axeC2, [ecmA]:pkaR(G135E/G261A), [pEcmA-Rm], neoR
[ecmA]:pkaR(G135E/G261A)constitutively active pkaR; point mutant (G135E/G261A) that is unable to bind cAMP under control of ecmA promotoraxeA1, axeB1, axeC1, [ecmA]:pkaR(G135E/G261A), neoR
[ecmA]:pkaR(G135E/G261A)/[ecmB-frag]:lacZconstitutively active pkaR (PKA regulatory subunit point mutant (G135E/G261A) that is unable to bind cAMP under control of ecmA promotor; coexpressed with lacZ under control of a fragment of the ecmB promotor (-877 to -1) which specifically directs expression in the stalk tubeaxeA2, axeB2, axeC2, [ecmA]:pkaR(G135E/G261A), [pEcmA-Rm], lacZ, [pST-gal], neoR
[ecmA]:YFPDH1 expressing YFP under the control of the prestalk ecmA promoteraxeA1, axeB1, axeC1, pyr5-6-[pRG24], ura-, [pTX-ecmA-YFP], neoRaxe, neoR, ura-, yfp
[ecmB]:lacZAX2 wild type cells marked with lacZ under the control of the prestalk ecmB promoteraxeA2, axeB2, axeC2, [p56Gal], neoRaxe,neoR
[ecmB]:lacZAX4 wild type cells marked with lacZ under the control of the prestalk ecmB promoteraxeA1, axeB1, axeC1, [ecmB/lacZ], neoR
[ecmB]:pkaCpkaC overexpressed under control of the prestalk emcB promotor in AX3 cellsaxeA1, axeB1, axeC1, pkaC, neoR
[ecmF]:expl3:mycmyc-tagged expl3 overexpressed in AX2axeA2, axeB2, axeC2, expl3:myc, [pLD1ΔBX[ecmF/expl3-myc], neoR
[ecmO]-ile-GFP(S65T)unstable GFP which does not accumulate with time and thus gives extremely weak fluorescence; directs expression in pstO cells axeA2, axeB2, axeC2, [ecmO/ile-wt-GFP]. neoR neoR
[expl7]:expl7:GFPexpl7 overexpressor under the control of its own promoteraxeA2, axeB2, axeC2, [expl7/expl7:GFP], neoR
[gpaA]:gpaAoverexpressor of gpaA under the control of its own promoter in a multicopy extrachromosomal vectoraxeA1, axeB1, axeC1, [gpaA]:gpaA, neoR
[gpaA]:gpaA(G45V)overexpressor of gpaA(G45V) (constitutively active mutant) under the control of its own promoter in a multicopy extrachromosomal vectoraxeA1, axeB1, axeC1, [gpaA]:gpaA(G45V), neoR
[gpaA]:gpaA(Q206L)overexpressor of gpaA(Q206L) (constitutively active mutant) under the control of its own promoter in a multicopy extrachromosomal vectoraxeA1, axeB1, axeC1, [gpaA]:gpaA(Q206L), neoR
[gpaB]:gpaB(Q208L)expression of gpaB (G alpha 2) with a point mutation in the GTPbinding/GTPase domain (Q208L)axeA1, axeB1, axeC1, [gpaB(Q208L)]
[gtaC]:IDQ-galgtaC promoter driving the labile IDQ-lacZaxeA1, axeB1, axeC1, [gtaC]:IDQ-gal, neoR
[hairpin]dcthairpin construct (dynhp) that silences dynacortin expressionaxeA1, axeB1, axeC1, [pREP], [hairpin]dct
[inviable]arcB-arcB is an essential gene in AX2 as determined by the "stop codon knock-in" methodaxeA1, axeB1, axeC1, arcB-, bsR
[inviable]arpB-haploid blasticidin resistant aprB null mutant cannot be obtained from segregating a diploid arpB-/arpB+ cell line xeA1, axeB1, axeC1, [PYR5-6-THY1], thy+/-[mycDdarpBpRHI76], bsR
[inviable]cofA-attempts to produce a cofA null mutant failed; transformants died after 5 daysaxeA2, axeB2, axeC2, cofA-, bsR
[inviable]fttBgene deletion yielded highly enlarged, fragile cells that died after a few days.axeA1, axeB1, axeC1, pyr5-6-[pRG24], [Ddp2-ORF-pyr5-6], ura+, fttB-, bsR
[inviable]lkb1-attempts to produce an lkb1-null mutant failed; RNAi knockdown mutant has severe defects suggesting the gene is essentialaxeA1, axeB1, axeC1, lkb1-, bsR
[inviable]phlp2-attempts to produce a phlp2- null mutant failed; transformants died after 5 daysaxeA1, axeB1, axeC1, phlp2-, bsR
[mrrA]:lacZlacZ under the control of the mrrA promoteraxeA2, axeB2, axeC2, mrrA:lacZ
[ndm]:ndm:RFPndm tagged with C-terminal RFP in AX3axeA1, axeB1, axeC1, ndm:RFP, bsr
[OE]:chlimoverexpressor of ChLimaxeA1, axeB1, axeC1, [OE]:chlim, neoR
[OE]:egeAegeA overexpressed in AX2axeA2, axeB2, axeC2, egeA, neoR
[OE]:gbfAoverexpressor of gbfA (G box-binding factor)axeA1, axeB1, axeC1, unk:gbfA, neoR
[OE]:GFP:gxcARacGEF1 overexpressor tagged with GFP at the N terminusaxeA1, axeB1, axeC1, unk:GFP:gxcA
[OE]:gpaDoverexpressor of gpaD (G alpha 4)axeA1, axeB1, axeC1, [OE]:gpaD
[OE]:gpaD/regA-regA null mutant in the overexpressor of gpaD (G alpha 4)axeA1, axeB1, axeC1, [OE]:gpaD, regA-[pregAKO], bsR, neoR
[OE]:gpaEhigh copy overexpressor of Gα5axeA1, axeB1, axeC1, [pJH206]HC, neoRaxe,neoR,premature tip formation
[OE]:HA:rab21overexpressor of rab21 with a N-terminal HA tagaxeA1, axeB1, axeC1, [OE]:HA:rab21, neoR
[OE]:HA:rab21(Q66L)overexpressor of rab21(Q66L) (constitutively active) with a N-terminal HA tagaxeA1, axeB1, axeC1, [OE]:HA:rab21(Q66L), neoR
[OE]:HA:rab21(T21N)overexpressor of rab21(T21N) (dominant negative) with a N-terminal HA tagaxeA1, axeB1, axeC1, [OE]:HA:rab21(T21N), neoR
[OE]:ipkA1ipkA1 overexpression in wild type axeA2, axeB2, axeC2, ipkA1, bsR
[OE]:itpk1itpk1 overexpression in wild type axeA2, axeB2, axeC2, itpk1, bsR
[OE]:limFlimF overexpressor in AX3axeA1, axeB1, axeC1, neoR, [OE]:limF
[OE]:pakCoverexpressor of pakCaxeA1, axeB1, axeC1, [OE]:pakC
[OE]:pdiApdi overexpressor controlled by pde late promoteraxeA1, axeB1, axeC1, [pLDI], neoRaxe,neoR,spores at base/thick stalks
[OE]:pdiApdi overexpressor controlled by pde late promoteraxeA1, axeB1, axeC1, [pLDI], neoRaxe,neoR,spores at base/thick stalks
[OE]:pdiAoverexpressor of phosphodiesterase inhibitor from the pde-aggregation promoteraxeA1, axeB1, axeC1, [pADI+pB10TP], neoRdelayed aggregation,neoR,axe
[OE]:pdiAphosphodiesterase-inhibitor overproducer (control plasmid without promoter)axeA1, axeB1, axeC1, [pCDI+pB10TP], neoRaxe,neoR,wt
[OE]:pdiAphosphodiestrase inhibitor (pdi) overproducer from the pde vegetative promoteraxeA1, axeB1, axeC1, [pVDI+pB10TP], neoRaxe,neoR,wt
[OE]:pdsACotransformant of AX3 with pB10T and pGPVC (prV-pde construct containing entire 5prime-untranslated region)axeA1, axeB1, axeC1, [pB10T+pGPVC], neoR
[OE]:rasB(G12T)Overexpressor of ras(G12T) (constitutively active)axeA2, axeB2, axeC2, [OE]:rasB(G12T)
[OE]:sgcA(1-2000)(N1106A):GFP/gca-/sgcA-overexpressor of sgcA with a mutation replacing the catalytic aspartate at position 1106 with an alanine residue and in which the C terminal 1000 amino acids have been removed, fused to GFP and expressed in sgcA-/gca- cells; the sGC protein remains completely cytosolicaxeA1, axeB1, axeC1, gcA-, sgcA-, unk:sgcA(1-2000)(N1106A):GFP, bsR, hygR
[OE]:sgcA(878-2843)(N1106A):GFP/gca-/sgcA-overexpressor of sgcA with a mutation replacing the catalytic aspartate at position 1106 with an alanine residue and in which the N terminal 877 amino acids have been removed, fused to GFP and expressed in gca-/sgcA- cells; the sGC protein remains completely cytosolicaxeA1, axeB1, axeC1, gcA-, sgcA-, unk:sgcA(878-2843)(N1106A):GFP, bsR, hygR
[OE]:sgcA(878-2843):GFP/sgcA-overexpressor of sgcA with a mutation removing the N terminal 877 amino acids, fused to GFP and expressed in gca-/sgcA- cells; the sGC protein remains completely cytosolicaxeA1, axeB1, axeC1, gcA-, sgcA-, unk:sgcA(878-2843):GFP, bsR, hygR
[OE]:sgcA(N1106A):GFP/gca-/sgcA-overexpressor of sgcA with a mutation replacing the catalytic aspartate at position 1106 with an alanine residue expressed in gca-/sgcA- mutantaxeA1, axeB1, axeC1, gcA-, sgcA-, unk:sgcA(N1106A):GFP, bsR, hygR
[OE]:sgcA:GFP/gca-/sgcA-sgcA fused to GFP expressed in gca-/sgcA- mutantaxeA1, axeB1, axeC1, gcA-, sgcA-, unk:sgcA:GFP, bsR, hygR
[OE]GFP:gxcA(1-750:764-1217)RacGEF1-delta IQ overexpressor marked with GFP at the N terminusaxeA1, axeB1, axeC1, unk:GFP:gxcA(1-750:764-1217)
[OE]GFP:gxcA(1-750:764-984)RacGEF1-deltaIQ/deltaPH overexpressor marked with GFP at the N terminusaxeA1, axeB1, axeC1, unk:GFP:gxcA(1-750:764-984)
[OE]GFP:gxcA(1-984)RacGEF1-delta PH overexpressor marked with GFP at the N terminusaxeA1, axeB1, axeC1, [OE]GFP:gxcA(1-984)
[OE]GFP:gxcA(568-1217)RacGEF1-deltaN overexpressor marked with GFP at the N terminusaxeA1, axeB1, axeC1, [OE]GFP:gxcA(568-1217)
[OE]mipp1mipp1 overexpression in wild typeaxeA2, axeB2, axeC2, mipp1, neoR
[OE]pdiApdi overproduceraxeA1, axeB1, axeC1, acrA1, tsgA1, bwn, pdiAaggregation defective,metR
[pdsA-agg]:pdsAOverexpressor of ePDE (extracellular phosphodiesterase) under the control of its aggregation promoter; pB10T + pGPA co-transformedaxeA1, axeB1, axeC1, [pB10T+pGPA], neoRaxe,neoR
[pdsA-ldev]:pdsAExtracellular phosphodiesterase (ePDE) overexpressor (from its late development promoter).axeA1, axeB1, axeC1, [pB10T+pGPL], neoRaxe,neoR,no fr. bodies
[pirA]:pirA:GFPinsertion of GFP at the C-terminus of the pirA geneaxeA1, axeB1, axeC1, pirA:GFP
[pkaC]:pkaCpkaC overexpressor, regulated by its endogenous upstream regionaxeA2, axeB2, axeC2, [K-Neo], neoR
[pkaC]:pkaC/nsfA(A1854Ttemperature sensitive nsfA mutant expressed in pkaC overexpressor cellsaxeA2, axeB2, axeC2, [pkaC]:pkaC, [K-Neo], nsfA2(A1854T, T1984A, C2131A, A2398T, T2574A), bsR, neoR
[pkaC]:pkaC/srfA-srfA null in pkaC overexpressoraxeA2, axeB2, axeC2, pkaC, [pK-Neo], srfA-, [srfA-KO], neoR, bsR
[pkaC]:pkaC/[dscC]:lacZlacZ under control of discoidin promotor expressed in pkaC overexpressoraxeA2, axeB2, axeC2, pkaC, [K-Neo], lacZ, neoR, hygR
[psmC1]:psmC1psmC1 overexpression under its own promoter in wild type strainaxeA1, axeB1, axeC1, psmC1+ [pEXP4(-)psmC1], neoR
[pspA]-ile-GFP(S65T)unstable GFP which does not accumulate with time and thus gives relatively weak fluorescence; expressed in prespore cells axeA2, axeB2, axeC2, [pspA/ile-wt-GFP], neoR neoR
< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 Next >
Home| Contact dictyBase| SOPs| Site Map  Supported by NIH (NIGMS and NHGRI)